bpc 157 made from BPC-157 BPC-157 Canada | Maple Research

The rapid attainment of peak plasma levels with parenteral administration makes this formulation particularly suitable for acute correction of deficiency states or for protocols requiring high systemic exposure

Studies on peripheral nerve crush injuries document accelerated nerve fiber regeneration and restored motor function in treated subjects

Inject a small dose of BPC-157 subcutaneously (250 to 600 micrograms daily, in my protocols) and your body responds the way it already knows how

Your information is never shared with third parties without explicit consent

Cycle length: 6-8 weeks is standard for GI applications

At this time, we only ship to the United States